These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 160)

  • 21. Analysis for procainamide and N-acetyl procainamide in plasma or serum by high-performance liquid chromatography.
    Rocco RM; Abbott DC; Giese RW; Karger BL
    Clin Chem; 1977; 23(4):705-8. PubMed ID: 844165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of procainamide and N-acetylprocainamide in serum by gas chromatography with nitrogen-selective detection.
    Yamaji A; Kataoka K; Oishi M; Kanamori N; Hiraoka E; Mishima M
    J Chromatogr; 1987 Mar; 415(1):143-7. PubMed ID: 2438294
    [No Abstract]   [Full Text] [Related]  

  • 23. Precaution in use of high-pressure liquid chromatographic simultaneous plasma procainamide and N-acetylprocainamide determination.
    Nation RL; Lee MG; Huang SM; Chiou WL
    J Pharm Sci; 1979 Apr; 68(4):532-4. PubMed ID: 438989
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
    Zema MJ; Mirando T
    Angiology; 1983 Jan; 34(1):32-9. PubMed ID: 6186164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
    Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM
    Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procainamide pharmacokinetics in beagles: urinary pH dependency and comparison with n-acetylprocainamide.
    Baer DT; Barkus JC
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):333-6. PubMed ID: 17895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the TDX fluorescence polarization immunoassays for procainamide and n-acetylprocainamide.
    Sonsalla PK; Bridges RR; Jennison TA; Smith CM
    J Anal Toxicol; 1985; 9(4):152-5. PubMed ID: 2412001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide.
    Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML
    Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration.
    Domoto DT; Brown WW; Bruggensmith P
    Ann Intern Med; 1987 Apr; 106(4):550-2. PubMed ID: 2435200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
    vasBinder E; Annesley T
    Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats.
    Watanabe J; Koyama I; Iwamoto K; Ozeki S
    J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging and renal clearance of procainamide and acetylprocainamide.
    Reidenberg MM; Camacho M; Kluger J; Drayer DE
    Clin Pharmacol Ther; 1980 Dec; 28(6):732-5. PubMed ID: 6160015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid and micro high-pressure liquid chromatographic method for simultaneous determination of procainamide and N-acetylprocainamide in plasma.
    Gadalla MA; Peng GW; Chiou WL
    J Pharm Sci; 1978 Jun; 67(6):869-71. PubMed ID: 660479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid fluorometric determination of procainamide hydrochloride dosage forms.
    TTan HS; Beiser C
    J Pharm Sci; 1975 Jul; 64(7):1207-10. PubMed ID: 239204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective plasma concentration of N-acetylprocainamide in rats.
    Yacobi A; Krasula RW; Lai CM; Kamath BL
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):197-200. PubMed ID: 432435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of N-acetylprocainamide as compared with procainamide in isolated rat atria.
    Refsum H; Frislid K; Lunde PK; Landmark KH
    Eur J Pharmacol; 1975 Aug; 33(1):47-52. PubMed ID: 1175691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
    Jaillon P; Winkle RA
    Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.